Alkem Laboratories Limited announced the appointment of Dr. Vikas Gupta as Chief Executive Officer of the company, with effect from September 22, 2023. According to the company’s exchange filing, “We wish to inform you that the based on the recommendation of Nomination and Remuneration Committee, the Board of Directors (“Board”) of Alkem Laboratories Limited (the…
Alkem Laboratories Limited announced the appointment of Madhurima Singh to its Board of Directors, effective December 20, 2021. According to the company’s exchange filing, “We wish to inform you that the Board of Directors (“Board ‘) of Alkem Laboratories Limited (the’ Company”) at its meeting held today i.e. on 20th December, 2021 has appointed Mrs.…
Alkem Laboratories Ltd, a multinational pharmaceutical company, is set to acquire assets related to Active Pharmaceutical Ingredient (API) Dronabinol from United States-based AbbVie Inc. for a cash consideration of $10 million. The expected date of completion was set to be on or before 31 st December 2019. As per BSE filing, the company said, “This…